Ifosfamide (Fresenius Kabi USA, LLC)
Welcome to the PulseAid listing for the Ifosfamide drug offered from Fresenius Kabi USA, LLC. This Alkylating Activity [MoA],Alkylating Drug [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Fresenius Kabi USA, LLC |
NON-PROPRIETARY NAME: | IFOSFAMIDE |
SUBSTANCE NAME: | IFOSFAMIDE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Alkylating Activity [MoA],Alkylating Drug [EPC] |
ROUTE: | INTRAVENOUS |
DOSAGE FORM: | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2003-01-28 |
END MARKETING DATE: | 0000-00-00 |
Ifosfamide HUMAN PRESCRIPTION DRUG Details:
Item Description | Ifosfamide from Fresenius Kabi USA, LLC |
LABELER NAME: | Fresenius Kabi USA, LLC |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 1(g/1) |
START MARKETING DATE: | 2003-01-28 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 63323-142_4c63407f-1190-43b8-9ce8-6d17042874f6 |
PRODUCT NDC: | 63323-142 |
APPLICATION NUMBER: | ANDA076078 |
Other IFOSFAMIDE Pharmaceutical Manufacturers / Labelers: